Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    HomeNewsAurobindo pharmaceuticals

    Aurobindo Pharmaceuticals

    Jump to

    • See lower levels in Aurobindo Pharmaceuticals: Sukhani

      Aurobindo Pharmaceuticals has done all the wrong things on the charts, made a rounding top, a bearish head and shoulder, breaking down from support levels and giving a message that a much deeper correction is still coming in, says Sudarshan Sukhani of s2analytics.com.

    • Hold Aurobindo Pharmaceuticals: Phani Sekhar

      Phani Sekhar, Fund Manager, Angel Broking is of the view that investor can hold Aurobindo Pharmaceuticals.

    • Buy Aurobindo, DCB; Sell JP Power: Cunha

      In CNBC-TV18's popular show Bull's Eye, Lancelot D Cunha, ITI Wealth Management shares trading strategy of the day.

    • Buy Aurobindo Pharma, Century Textiles, Sun TV : Merani

      In CNBC-TV18's popular show Bull's Eye, Nooresh Merani, AMSEC Research shares trading strategy of the day.

    • PN Vijay suggests 2 midcap stocks for handsome returns

      In an interview with CNBC-TV18, portfolio manager PN Vijay, spoke about his multi-bagger ideas and his reading of the market.

    • Aurobindo Pharma Dec qtr PAT seen down at Rs 157.2cr: Karvy

      Karvy Stock Broking has come out with its earning estimates on pharma sector for the quarter ended December 2010. According to the research firm, Aurobindo Pharmaceuticals December quarter sales are expected to go up by 23.4% at Rs 1129.9 crore, Year-on-Year, (YoY) basis.

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347